{"symbol": "RYTM", "companyName": "Rhythm Pharmaceuticals Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.rhythmtx.com", "description": "Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.", "CEO": "Keith Gottesdiener", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}